Chapter 11 principles of pharmacology

Option B: Inhibitor of dopamine & NE reuptake accurately describes bupropion's mechanism of action, as it primarily inhibits the reuptake of dopamine and norepinephrine, making it effective for depression and smoking cessation. This dual action contributes to its unique profile among antidepressants.

Option A: Norepinephrine serotonin reuptake inhibitor misrepresents bupropion's mechanism, as it does not primarily target serotonin reuptake, which is characteristic of other antidepressants like SNRIs.

Option C: Agonist/Partial 5HT1A agonist incorrectly categorizes bupropion, as it does not act on serotonin receptors in this manner, which is more typical of certain other antidepressants.

Option D: Selective serotonin reuptake inhibitor is inaccurate for bupropion, as it does not selectively inhibit serotonin reuptake, distinguishing it from SSRIs like fluoxetine or sertraline.

Takeaways: Bupropion functions as an inhibitor of dopamine & NE reuptake, differentiating it from other antidepressants that primarily affect serotonin levels, which requires understanding its unique pharmacological profile for effective patient management.

Option D: Synergy describes the phenomenon where the combined effect of two drugs is greater than the sum of their individual effects. In this case, gentamicin and ampicillin work together to enhance the antibacterial activity against potential pathogens in neonatal sepsis, demonstrating their synergistic relationship.

Option A: Agonism refers to the action of a substance that activates a receptor to produce a biological response. This concept does not apply to the interaction between gentamicin and ampicillin.

Option B: Anergy is a state of immune unresponsiveness. It does not pertain to the pharmacological interaction between the two antibiotics in this scenario.

Option C: Symbiosis generally refers to a mutually beneficial relationship between different organisms. This term does not accurately describe the pharmacological interaction between gentamicin and ampicillin.

Takeaways: Understanding the principle of synergy is crucial in pharmacology, as it highlights how certain drug combinations can enhance therapeutic effects, such as the synergy seen with gentamicin and ampicillin in treating infections, which requires appropriate antibiotic selection and monitoring for optimal patient outcomes.

Option A: The particle size of the dispersed solid in a suspension is usually greater than 0.5 µm, which is a defining characteristic of suspensions. This size allows for the solid particles to remain suspended in the liquid without settling quickly, ensuring the mixture remains homogenous for a longer duration.

Option B: The particle size of 0.4 µm does not meet the criteria for suspensions, as it is below the typical threshold of 0.5 µm, where particles may not remain suspended effectively.

Option C: A particle size of 0.3 µm is also below the standard size for suspensions, indicating that such particles would likely settle out of the mixture rather than remain dispersed.

Option D: The size of 0.2 µm is significantly smaller than the required size for a suspension, which typically necessitates particles larger than 0.5 µm to maintain suspension stability.

Takeaways: The defining characteristic of a suspension is that the dispersed solid particles are usually greater than 0.5 µm, which ensures they remain suspended in the liquid, requiring proper formulation techniques in pharmacy to achieve stability.

Option D: Negative log of the H⁺ concentration accurately describes how pH is calculated. The pH scale measures the acidity or alkalinity of a solution, with lower pH values indicating higher acidity due to increased hydrogen ion concentration. Thus, pH = -log[H⁺].

Option A: Log of the hydroxyl ion (OH) concentration does not define pH. While hydroxyl ions are related to pH, the pH calculation specifically involves hydrogen ions, not hydroxyl ions.

Option B: Negative log of the OH⁻ concentration is not how pH is determined. This option confuses the relationship between pH and pOH; pOH is calculated using hydroxyl ion concentration, not pH.

Option C: Log of the hydrogen ion (H⁺) concentration fails to account for the negative sign in the pH formula. The correct calculation requires taking the negative logarithm of the hydrogen ion concentration to yield the pH value.

Takeaways: Understanding that pH is defined as the negative log of the hydrogen ion concentration is essential for assessing acidity and alkalinity in clinical settings, which requires accurate measurement of pH for patient care.

Option C: Metoprolol is metabolized by enzymes in the hepatic smooth endoplasmic reticulum, primarily through the cytochrome P450 system. This process is crucial for the drug's clearance and efficacy, as it transforms the drug into metabolites that can be excreted. Understanding this metabolic pathway is essential for managing dosing and potential drug interactions in patients.

Option A: Levodopa is primarily converted to dopamine in the brain and does not undergo significant hepatic metabolism in the smooth endoplasmic reticulum. Its metabolism is mainly peripheral rather than hepatic.

Option B: Tyramine is metabolized by monoamine oxidase (MAO) rather than the hepatic smooth endoplasmic reticulum, which is a different metabolic pathway. This distinction is important for understanding dietary restrictions in patients taking MAO inhibitors.

Option D: Suxamethonium is rapidly hydrolyzed by plasma cholinesterase, not metabolized in the hepatic smooth endoplasmic reticulum. Its metabolism is primarily extrahepatic, which is critical for its short duration of action.

Takeaways: Understanding the metabolic pathways of drugs like metoprolol, which are processed by the hepatic smooth endoplasmic reticulum, is vital for effective pharmacotherapy and managing potential drug interactions, as outlined in this resource on drug metabolism.

Option A: Mycoplasma pneumoniae is effectively treated with clarithromycin, as it is a macrolide antibiotic that targets atypical bacteria, making it suitable for respiratory infections caused by this organism.

Option B: Legionnaire's disease is primarily treated with fluoroquinolones or azithromycin, not clarithromycin, which is less effective against Legionella pneumophila.

Option C: Campylobacter enteritis is typically treated with fluoroquinolones or macrolides like azithromycin, while clarithromycin is not the first-line treatment for this condition.

Option D: Non-specific urethritis is generally treated with azithromycin or doxycycline, and clarithromycin is not commonly indicated for this type of infection.

Takeaways: Clarithromycin is particularly effective against atypical pathogens such as Mycoplasma pneumoniae, which requires appropriate antibiotic selection for respiratory infections to ensure effective treatment.

Option C: Levodopa is absorbed predominantly through active transport systems, specifically via the large neutral amino acid transporters in the gastrointestinal tract. This mechanism is crucial for its effectiveness in treating Parkinson's disease, as it competes with other amino acids for absorption, highlighting the importance of dietary considerations in its administration.

Option A: Paracetamol (acetaminophen) is absorbed primarily through passive diffusion rather than active transport, allowing for rapid absorption in the gastrointestinal tract without the need for specific transport mechanisms.

Option B: Phenytoin absorption occurs mainly through passive diffusion, as it is a highly lipophilic drug, which does not rely on active transport systems for its gastrointestinal absorption.

Option D: Methyldopa is absorbed via passive diffusion as well, and while it may utilize some transport mechanisms, it does not predominantly rely on active transport systems for absorption in the body.

Takeaways: Understanding the absorption mechanisms of drugs, such as how levodopa utilizes active transport systems, is essential for optimizing therapeutic outcomes and managing patient care effectively, especially in conditions like Parkinson's disease that require careful medication management. For more information on drug absorption mechanisms, see this NIH resource.

Option D: Atropine is combined with diphenoxylate to relieve its spasmogenic effect and discourage abuse with prolonged use. Atropine reduces gastrointestinal motility and helps manage diarrhea while also deterring misuse of diphenoxylate, which can lead to dependence due to its opioid-like properties.

Option A: While atropine does relieve the spasmogenic effect of diphenoxylate, it does not address the concern of potential abuse, making this option incomplete.

Option B: This option focuses solely on discouraging abuse but neglects the spasmogenic effect that atropine also addresses, thus failing to capture the full rationale for the combination.

Option C: Atropine does not antagonize urine retention liability; rather, it primarily affects gastrointestinal motility. This option misrepresents the pharmacological actions of atropine in this context.

Takeaways: The combination of atropine and diphenoxylate effectively manages diarrhea by relieving spasmogenic effects and discouraging abuse, highlighting the importance of understanding drug interactions and their clinical implications, as seen in this overview of antidiarrheal medications.

Option A: Bronchial smooth muscle does not contain nicotinic receptors; instead, it primarily has muscarinic receptors that mediate bronchoconstriction. Nicotinic receptors are found at the neuromuscular junction and in autonomic ganglia, but not in bronchial smooth muscle.

Option B: Adrenal medullary cells contain nicotinic receptors, which are stimulated by acetylcholine, leading to the release of catecholamines into the bloodstream.

Option C: Parasympathetic ganglia are characterized by nicotinic receptors that facilitate synaptic transmission between preganglionic and postganglionic neurons.

Option D: Skeletal muscle has nicotinic receptors at the neuromuscular junction, which are essential for muscle contraction upon stimulation by acetylcholine.

Takeaways: Understanding the distribution of nicotinic receptors is crucial for pharmacological applications, particularly in the context of autonomic nervous system function and muscle physiology, as seen in the role of nicotinic receptors in neurotransmission.

Option B: Constant fraction of the drug is eliminated per unit time is a defining characteristic of first-order kinetics, not zero-order kinetics. In zero-order kinetics, a constant amount of the drug is eliminated per unit time, regardless of concentration, leading to a variable half-life depending on the drug concentration.

Option A: Half life (t1/2) of the drug is different at high and low concentration accurately describes zero-order kinetics, where the half-life varies with concentration due to the constant amount of drug eliminated over time.

Option C: Steady-state plasma concentration is not achieved is misleading; while it may take longer to reach steady state in zero-order kinetics, it can still be achieved depending on the dosing regimen and the drug's elimination characteristics.

Option D: Ethanol is a famous example of a drug with zero-order kinetics, which is true as ethanol is eliminated at a constant rate regardless of its concentration in the bloodstream.

Takeaways: Understanding that in zero-order kinetics, a constant amount of drug is eliminated per unit time is crucial for predicting drug behavior and requires knowledge of pharmacokinetics for effective medication management in clinical practice.

Option D: The passage of drug molecules from a region of high drug concentration to a region of low drug concentration is known as simple diffusion. This process occurs without the need for energy and is driven by the concentration gradient, allowing substances to move freely across cell membranes until equilibrium is reached.

Option A: Active transport involves the movement of molecules against their concentration gradient, requiring energy in the form of ATP. This is not the mechanism described in the question.

Option B: Bioavailability refers to the proportion of a drug that enters the circulation when introduced into the body and is available for therapeutic effect. It does not describe the movement of molecules between concentration gradients.

Option C: Biopharmaceutics is the study of the relationship between the physical and chemical properties of drugs and their pharmacological activity. This term does not pertain to the specific process of molecular movement described in the question.

Takeaways: Simple diffusion is a fundamental process where drug molecules move from areas of high concentration to low concentration, emphasizing the importance of understanding drug distribution in pharmacology, which requires knowledge of pharmacokinetics and drug absorption for effective patient care.

Option D: Gamma emissions from the decay of radionuclides are most commonly used in nuclear medicine imaging due to their ability to penetrate tissues and provide high-resolution images. Gamma rays are emitted during the decay of certain isotopes used in diagnostic imaging, allowing for effective visualization of internal structures and functions.

Option A: X-rays are not primarily derived from radionuclide decay but are produced by the interaction of high-energy electrons with matter, making them less relevant in the context of nuclear medicine imaging.

Option B: Beta emissions are less commonly used in imaging as they have limited penetration ability and are primarily utilized in therapeutic applications rather than diagnostic imaging.

Option C: Alpha emissions have very low penetration power and are not suitable for imaging purposes; they are primarily used in targeted alpha therapy rather than in diagnostic imaging techniques.

Takeaways: Understanding that gamma emissions are the primary choice for nuclear medicine imaging due to their penetrating ability and imaging quality is crucial for effective diagnostic practices, as highlighted in this resource on nuclear medicine imaging.

Option A: Tranylcypromine can lead to severe hypertension when consumed with tyramine-rich foods, such as old cheese, due to its inhibition of monoamine oxidase (MAO), which normally breaks down tyramine. This interaction can cause a hypertensive crisis, characterized by dangerously elevated blood pressure levels.

Option B: Moclobemide is a reversible MAO-A inhibitor that does not typically cause severe hypertension with tyramine intake, as it allows for some breakdown of tyramine, reducing the risk of hypertensive crises.

Option C: Selegiline, while an MAO-B inhibitor, can also lead to hypertensive reactions if taken in higher doses or in its non-transdermal form, but it is less likely to cause severe hypertension with tyramine than tranylcypromine.

Option D: Bupropion does not interact with tyramine and does not cause hypertensive crises related to cheese intake, as it primarily acts as a norepinephrine-dopamine reuptake inhibitor without MAO inhibition.

Takeaways: Understanding the dietary restrictions associated with monoamine oxidase inhibitors, such as tranylcypromine, is crucial for preventing hypertensive crises, which requires patient education on food interactions to ensure safety and effective treatment.

Option D: Ketoconazole is an antifungal medication that acts as an enzyme inhibitor, specifically inhibiting cytochrome P450 enzymes, which can affect the metabolism of various drugs. This property is significant in pharmacology as it can lead to increased drug levels and potential toxicity when co-administered with other medications that are metabolized by the same enzymes.

Option A: Chloramphenicol does not primarily function as an enzyme inhibitor; it works by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit.

Option B: Ciprofloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, but it does not act as an enzyme inhibitor in the context of human metabolic enzymes.

Option C: Erythromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, rather than functioning as an enzyme inhibitor affecting metabolic pathways.

Takeaways: Understanding the role of enzyme inhibitors like ketoconazole is crucial in pharmacology, particularly regarding drug interactions and metabolism, which requires careful consideration of enzyme inhibition in drug therapy to avoid adverse effects.

Option C: More liable to induce rebound insomnia & disturbance in REM sleep than benzodiazepines is not true. Zolpidem, while it can cause rebound insomnia, generally has a lower incidence of this effect compared to traditional benzodiazepines, which are more likely to disrupt sleep architecture and REM sleep due to their longer half-lives and broader receptor activity.

Option A: It is a short acting hypnotic causing less hang over than benzodiazepines. Zolpidem is indeed a short-acting hypnotic, which typically results in less residual sedation or hangover effects compared to longer-acting benzodiazepines.

Option B: It acts on benzodiazepine-1 receptor. Zolpidem selectively binds to the benzodiazepine-1 receptor subtype, which is responsible for its sedative effects, distinguishing it from other benzodiazepines that act on multiple receptor subtypes.

Option D: Its use is associated with less tolerance and dependence than benzodiazepines. Zolpidem is associated with a lower risk of tolerance and dependence compared to benzodiazepines, making it a preferred option for short-term management of insomnia.

Takeaways: Zolpidem is a short-acting hypnotic that generally has a lower risk of rebound insomnia and REM sleep disturbance compared to benzodiazepines, which requires careful consideration of patient history and sleep patterns when prescribing for insomnia.

Option C: Ion trapping the amitriptyline in the urine to hasten elimination is accomplished by giving bicarbonate. Bicarbonate increases the urine pH, converting the weakly acidic amitriptyline into its ionized form, which is less reabsorbed in the renal tubules. This facilitates its excretion and reduces toxicity in the body.

Option A: Bicarbonate is the appropriate treatment for a weak acid overdose; ammonium chloride would not be effective in this scenario. Bicarbonate raises urine pH, aiding in the elimination of amitriptyline.

Option B: Bicarbonate does not trap amitriptyline in the blood; rather, it alters the urine pH to promote elimination. The mechanism involves ionization in the renal system, not blood retention.

Option D: Bicarbonate does not chemically inactivate amitriptyline; it changes the pH of urine to facilitate the drug's excretion. The drug remains pharmacologically active until eliminated from the body.

Takeaways: The administration of bicarbonate in cases of weak acid overdose, such as amitriptyline, promotes ion trapping in the urine, enhancing elimination and reducing toxicity, which requires understanding the principles of acid-base balance in pharmacology for effective treatment.

Option A: Intestinal obstruction if not taken with plenty of fluids accurately describes a significant adverse effect of Bran/Psyllium, which are bulk-forming laxatives. These agents require adequate fluid intake to prevent the formation of a mass that can obstruct the intestines, particularly in patients with pre-existing gastrointestinal conditions.

Option B: Mutagenic is not associated with Bran/Psyllium. These substances do not possess mutagenic properties and are primarily used for their fiber content to aid in bowel regularity.

Option C: Lipid pneumonia is unrelated to Bran/Psyllium. This condition typically arises from the aspiration of oils or fats, not from the ingestion of fiber supplements.

Option D: Flatulence & aggravation of diabetes does not accurately reflect the primary adverse effects of Bran/Psyllium. While flatulence can occur due to increased fiber intake, it does not specifically aggravate diabetes, as fiber can actually help in managing blood sugar levels.

Takeaways: Understanding the need for adequate fluid intake with bulk-forming laxatives like Bran/Psyllium is crucial to prevent complications such as intestinal obstruction, which requires patient education on proper usage to ensure safe and effective treatment.

Option C: Pulverization and intervention is the technique typically used to mill camphor, as it involves reducing the particle size through mechanical means, which is essential for achieving the desired consistency in pharmaceutical preparations.

Option A: Trituration refers to the process of grinding a substance into a fine powder, but it is not specifically the technique used for camphor milling.

Option B: Levigation involves mixing a solid with a liquid to form a paste, which is not the primary method for milling camphor.

Option D: Geometric dilution is a method used to ensure uniform distribution of a potent drug in a larger volume of diluent, not a milling technique.

Takeaways: Understanding the appropriate milling technique, such as pulverization and intervention for substances like camphor, is crucial in pharmaceutical compounding to ensure proper formulation and efficacy. For more on compounding techniques, see this resource on pharmaceutical compounding.

Option B: Melphalan is a potent alkylating agent that is well-documented to cause profound and prolonged myelosuppression, particularly affecting bone marrow function, leading to decreased blood cell production and increased risk of infection and bleeding.

Option A: Chlorambucil, while also an alkylating agent, typically causes less severe myelosuppression compared to melphalan and is often used in chronic conditions with a more favorable safety profile.

Option C: 1,3-bis (2 chloroethyl)-1-nitroso-urea (BCNU) can cause myelosuppression, but it is generally less pronounced and more variable than that seen with melphalan, making it less associated with profound effects.

Option D: Bleomycin primarily causes pulmonary toxicity and is not significantly associated with myelosuppression, distinguishing it from the other agents listed, particularly melphalan.

Takeaways: Melphalan is associated with profound and prolonged myelosuppression, a critical consideration in chemotherapy management, requiring careful monitoring of blood counts during treatment to prevent complications.